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Antimelanosome-associated monoclonal antibody has rec-
ognized the co mmon antigenic determinant of melano-
som es and cell surface of pigment cell s, and it is sugges ted 
that melanosomes playa signiftcant role as an antigen in 
progressive depigm entary disorders, in whi ch melanocytes 
are selectively altered and disappear presumably by auto-
antibodies in vivo. 
Mouse lnyeloma cells were fu sed with spleen cells from 
BALB /c mice immunized with a melanosomal fraction sep-
arated from human melanotic melanoma cells (Mm-l-:JCK). 
T he monoclonal antibody (MoAb) A4Fll has been found 
to react with premelanosomes, melanosomes, and proba-
bly with Gol gi-associated endoplasmic reticulum lyso-
somes, but not with mjtochondria , nuclei, and cytosol fi:om 
human melanoma cells, by immunoelectron microscopy 
using the saponin permea tion method , which w as carried 
out together with indirect radioimmunoassay and quanti-
tative absorption assay . Sodium dodecyl sul fa te-poly-
I n spite of many reports extensively describin g cell surface reactive antimelano ma m onoclonal antibodies (M o Abs) [1-6], th e interrel ationship of such m elano m a cell sur£1ce antigens and mclanoso m es has not been clarified . In 1981 and 1982, Wi lson et al [7] and N atali et al [8] 
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Abbreviations: 
ER: endoplasmic reticulum 
GERL: Golgi-associated endoplasmi c reticulum lysosome 
!I F: indirect immunofluorescence 
MoAb: monoclonal antibody(ies) 
PAGE: polyacrylamide gel electrophores is 
PBS: phosphate-buffered saline 
QAA: quantitative absorption assay 
RIA: radioimmunoassay 
SDGU: sucrose density gradient ultracentrifugation 
SDS: sodium dodecyl sulfate 
acrylamide gel electrophoresis and immunoblotting using 
melanosome preparations have revealed the antigen(s) re-
active with the M oAb A4Fll in 3 bands corresponding to 
M,50,000 , 18,000, and 17,000. 
Cell bindin g assay has shown the reactivity of the M oAb 
A4Fll with the cell surface of human norm al m elanocytes 
and 1T1elanoma cells, but not with other mammalian mel-
anoma cells or with hum an non pigment cells exa mined . 
lndirect immunofluorescence on cultured cells and frozen 
sections has revealed distinct granular reactivity not only 
with hum an melanotic melanoma, but also with junctional 
and intradermal nevi, cultured malignant blue nevus cells, 
as welJ as normal melanocytes. 
The above evidence has indica ted the presence of an an-
tigenic determinant common to the intracellular melano-
genic compartments and to the. celJ surface of human pig-
ment cells, regardless of their oncog~nic differentiation status·. 
} Jnvest D erl1lafo/ 87:89-94, 1986 
reported the presence of cytoplasmic antigen defined by M oA b 
in human mali gnant m elano ma cell s, but its relationship w ith 
m elanosom es and other intracellular m elanogenic compartments 
was no t described . Premelanoso m es and melanosomes have been 
reported to possess the antigenicity revealed by the blastogenic 
responses of lymphocytes fro m melanoma-beari ng hamsters by 
Our group [9]. In o rder to defi ne the distribution and interrela-
ti onship of mel anosom al antigen on int racellular organelles and 
cell surface, we have es tablished antihuman m elanosome-asso-
ciated MoAb. 
We have furth er ruscussed the intracellular sorting-out and the 
transportin g pathway of this antigen(s) recognized by th e M oA b 
A4F11 , based on couplin g the present data with o ur recent bio-
chemi cal and ultrastru ctural findin gs [1 0, 11] on the ty rosinase 
glycosy lation and the processing pathway within melanogenic 
compartm ent of melanom a cells. 
Doniach ct al [1 2] similarl y reported that the organ- specifi c 
microso m al antigens, such as thyroid, gas tric, o r ad renal, were 
also ex pressed on the cell surface of the relevant endocrine and 
paracrine cells, as we have suggested here in pigment cells. 
MATERIALS AND METHODS 
Source and Separation of Melanosornes M elanosomes were 
separa ted from Mm-l-JCK human m elanotic melano m a inocu-
lated into nude mice by sucrose density gradient ultra centrifu-
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Table I. T he Enzyme Activities of Subcellular Fractions of Mm-1-JCK Cells after SDGU· 
Fractions Tyrosinase" 
Crude 
Small granule 
Smooth endoplasmic reticulum 
Rough endoplasmic reticulum 
Mitochondria 
Premelanosome 
Melanosome 
' SDGU : sucrose density gradient ultracentrifugation. 
'6 Em 1l0 min / mg protein . 
'nmol/min/ mg protein. 
'nmol inorganic phosphate/ min /mg protein . 
0.016 
0.020 
0.018 
0.016 
0.017 
0.034 
0.032 
gation (SDGU), as described previously [1 3]. Mm-1-JCK was 
established in the Central Institute for Experimental Animals , 
Yokohama, Japan. 
Purity of Melanosornal Fraction and Other Fractions The 
purity of each fraction after SDGU was exa mined by the m arker 
enzymic activi ties . Melanoso mal fract ion was also examined by 
electron microsco py. Tyrosinase activity was meas ured following 
the method of H amada and Mishima [14].Thiamine pyrophos-
phatase and NADH-cytochrome c reductase activities w ere ex-
amined by the methods described by Yamazaki and H ayashi [1 5], 
Table II. Reactivity of the M oA b A4Fll with Skin Tumors 
and N ormal Adult Organs· 
Tumor biopsies 
Primary nodular melanotic melanoma 
Metastatic melanom a: lymph nodes 
Junction nevus 
Compound nevus 
Congenital giant nevus 
Squamous cell ca rcinoma 
Basal cel l epithalioma 
Eccrine ductocarcinoma 
Normal adult organs" 
Skin: melanocytes 
Adrenal 
Gall-bladder 
Pancreas 
Small intestine 
Stomach 
Tonsils 
Skin: eccrine secretary portion, luminal site 
Aorta 
Brain 
Cardiac muscle 
Esophagus 
Kidney 
Liver 
Lung 
Rectum 
Spleen 
Thyroid 
Trachea 
Skin keratinocytes 
apocrine 
Staining Pattern 
Strong' 
Strong 
Strong 
Strong 
Strong 
Negative 
Negative 
Negative 
Strong 
Weak' 
Weak 
Weak 
Weak 
Weak 
Weak 
Weak 
Negative 
Negative 
Negative 
Negative" 
Negative 
Negative" 
Negative" 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
II Indircct immunofluorescence assay perfo rmed on frozen sections. 
'Organs were ob tained from Department of Legal Medicine, Kobe University 
School of Medicine. 
'Refers to the intensity of the stain and the freq uency of stained areas. See Materials 
alld Methods. 
'Only a few positive cells whose nature has not been determined. 
NADH-
Cytochrome C Glucose-6- Thiamine 
Reductase' Phosphatased Pyrophosphatased 
25.00 4.0 55.6 
10.00 9.0 73.3 
43.75 9.0 70.0 
13.75 9.0 72.8 
75.00 0.0 36.2 
11.25 0.0 16.3 
6.25 0.0 13.0 
and M ackler [1 6], respectively. Glucose-6-phosphatase was as-
sayed by the m ethod of Swanson [17] . 
The results are shown in Table l. Premelanosomal and m elan_ 
oso mal fractions contain the highest ·tyrosinase activity, as well 
as a little o ther enzy mic activity . Small granule, rough and smooth 
endoplasmic reticulum (ER) fractions contain rather high enzymic 
activity of thi amine pyrophosphatase. 
Cell and Cell Lines The human culture cell lines used in the 
indirect radioimmunoassay (RIA) are shown in Fig 5. The cells 
were maintained in RPMI-1 640 with 10% fetal calf serum and 1 
mM glutamine. 
Human malignant blue nevus cells used in the indirect im-
munofluorescence (IIF) tes t w ere obtained from freshly isolated, 
histologically confirmed surgical specimens. Human normal m el_ 
anocytes w ere obtained from adult foreskin following the method 
of Eisinger and M arko [1 8]. 
Production and Binding Specificity of the MoAb 
A4Fll BALB/c mice were immunized subcutaneously 4 times 
at 1-week intervals by melanosomal fraction with complete Freund's 
adjuvant. After a 10-day rest period, the mice were given i. v. 
inj ections of m elanosomal fraction. The spleen was removed 3 
days after the last inj ection, and the spleen cells were fused with 
P3X63Ag8Ul mouse myeloma cells at a ratio of 2 spleen 
cells/myeloma cell in 1 ml of50% (v/v) polye thylene glycol 1500. 
The binding specificity of the MoAb A4F11 was determined by 
its reactivity in the indirect RIA on each fraction separated from 
Mm-l -jCK, and on live cells of various origins using 125I-labeled 
rabbit antimouse immunoglobulin provided by the D epartment 
of immunology, C hiba University School of M edicine, Chiba, 
J apan. '251-Labeled rabbit antimouse immunoglobulin had been 
Small granule 
Smooth ER 
Rough ER 
Mitochondria ~ 
P reme lanosome ti;;;;;======================:J 
-Melanosome 
2 3 4 5 
cpm bound (X 10 3 ) 
6 
Figure 1. Reactivity of the MoAb A4F11 with subcellular fractions of 
human melanoma cells (Mm-1-JCK; Opfll bar) and human normal liver 
as a control (hatched bar) in the indirect RIA. Each fraction examined was 
adjusted in the same protein concentration before assay. Solid bar repre-
sents the reactivity of a control MoAb (IgG2b) with subcellular fractions 
of Mm-1-JCK. 
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Figure 2. Quantitative absorption of the MoAb A4Fll. Binding assay 
using melanosomal fraction as target. Each point represents cpm bound 
by the M oAb A4Fl1 after absorption of 5 j.l.g the MoAb with the con-
centra tion of fractions incjicated. Asterisk indicates cpm of 1251_labeled 
rabbit anti mouse immunoglobulin bound by the unabsorbed supernatant; 
closed circle = mitochondria fraction open circle = melanosome fraction , 
closed square = smooth ER fraction , open square = rough ER fraction, 
closed triangle = premelanosome fraction, from human melanoma cel ls 
(Mm-l-JCK), diamolld i'l sqllare = mitochondria fraction , Ope/l star = 
smooth ER fraction from human no [mal liver. 
absorbed before application by target hom ogenates to avoid non-
specific binding. Subcellular fractions separated by SDGU from 
human normal liver [1 9] were applied as a control. The antibody 
was an IgG2b immunoglobulin as determined in Ouchterlony 
immunodiffusion. The antibody from serum-free culture super-
natant was used. The sam e immunoglobulin subclass (lgG2b) MoAb 
(mouse antihuman IgE; Miles Laboratories, U .S.A.) served as a 
contro l an tibody . 
Quantitative Absorption Assay (QAA) In order to further 
demonstrate the specificity of the MoAb A4F11, the QAA was 
carried out. Suspensions containing different concentrations of 
each fraction from melanoma and liver (0.05-200 /-tg/100 /-tl) were 
added to 5 /-tg of the MoAb A4Fll. After absorption, the re-
maining binding activity in the supernatant for melanosomal frac-
tion was then tested by indirect RIA. 
liF Test Cells attached to coverslips, or frozen sections were 
washed 3 times with phosphate- buffered saline (PBS). After ace-
tone fixation, 50 /-tl of hybridoma-superna tant or 50 /-tl of ascites 
fluid diluted 1 : 1000 was applied to the examined cells or tissues 
and incubated for 30 min at room temperature. The specimens 
were washed 3 times with PBS and incubated for 30 min w ith 
fluorescein-conjuga ted rabbit antimouse IgG (ab/h (Wako Pure 
Chemical Industries, J apan) at 1: 20 dilution w ith PBS. After 3 
rinses with PBS, the specimens were observed for fluorescence 
staining. A normal mouse serum was used as a negative control. 
The designation "positive immunofluorescence" used in Table II , 
was based both on the intensity of staining and on the distribution 
of stained areas. The term "weak staining" refers to a faintly 
granular fluorescent pattern evenly distributed, while the term 
"strong staining" refers to a grossly granular pattern distributed 
homogeneously. 
Figure 3. Immunoe!ectron microscopic examination on Mm-l-JCK cells 
with the MoAb A4Fll, using the saponin permeation method. a, Pre-
melanosomes and melanosomes show distinctive deposition of an elec-
tron-dense reaction product indicating the loca lization of the MoAb A4Fl1 
(arrows). Bar = 1 j.l.m . b, Further electron-dense reaction product appears 
to be deposited on tubular structure in the vicinity of Golgi-cisterna 
(arrows). N = nucleus. Bar = 0.5 j.l.m . c, Control electron micrograph 
of Mm-l-JCK cells treated only with the saponin permeation method . 
N = nucleus. Premelanosomes (arrows). Bar = 0.5 j.l.m . 
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Figure 4. Indirect immunofluorescence 
staining of acetone fixed cultured Mm-
l-JCI< ce lls (a) , malignant blue nevus cells 
(b), normal mebnocytes (c) wi th the 
M oA b A4Fll. Cytoplasmic g ranular 
pattern has been observed ( X 264). d, In 
the mixed culture of Mm-l-JC K cells 
and normal fib ro blas ts (arrow), no dis-
tinct stainin g has been observed in nor-
mal fibrobl as ts, comparing with Mm-I-
JC I< ce lls ( x 11 4). 
Immunoelectron Microscopy Using the Saponin Permea-
tion Method lmmunoelectron microscopy was carried out by 
a modification of the meth od of Lo uvard et al [20] . Mm-1-J CK 
cells grown on cell culture dishes, were fi xed with 2% (wt/vol) 
paraformaldehyde, 0.02% (wt/vo l) glutarald ehyde in 0.1 M cac-
odylate buffer pH 7.4 for 30 min at 4°C and then was hed 3 tim es 
with PBS containing 50 111M NH4Cl. The cells were treated with 
the MoAb A4Fl1 (0.02 mg/ml) in PBS containing 0.02% (wt/vol) 
saponin and 0.5% (wt/vol) bovine serum albumin for 30 Inin at 
room temperature. The cells were then washed 3 times with PBS 
containing 0.02% (wt/vol) sa ponin and trea ted with rabbit an-
timouse IgG conju ga ted to horseradish peroxidase (Cappel Lab-
oratories, U.S.A .) in the same buffer used for the first antibody . 
After was hing 3 times with PBS con taining 0.02% (wt/vol) sa-
ponin , the cells were fixed with 2.5% (wt/vol) glutaraldehyde in 
0.1 M cacodylate buffer pH 7.4. After was hing 3 times w ith 0.1 
M Tris-HCI pH 7.6, the cell s were incubated in 0.1 M Tris-HCI 
containing 0.5 mg/ml diaminobenzidine and 0.075% (vol/vol) 
H20 2 for 45 min at 37°C. The cell s were then washed with cac-
odylate buffer, postfixed for 30 min in 1 % (wt/vol) OSO'1 at 4°C, 
stained in 1 % (wt/vol) uranyl acetate for 1 h at room temperature, 
dehydrated in a graded ethanol seri es, and embedded in Epon 
812. Thin sections were observed usin g JEM 100S electron nl.i-
croscope. 
Immunoblot Analysis The antigen(s) recognized by ·the MoAb 
A4Fl1 was analyzed by sodium dodecyl sulfate-polyacry lamide 
gel electrophoresis (SDS-PAGE) [21] and immunoblotting [22,23]. 
Melanosomal frac tion of Mm-l-JCK and small granule fraction 
of human normal liver were suspended in 100 J.LI of PBS con-
taining 1 mM phenylmethylsulfonyl fluorid e and 50 J.LI of sa mple 
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Figure 5. Cell surface reactivity spectrum o f the MoAb A4Fl1. Results 
are presented as cpm bound per 5 x J 05 cell s after subtraction of control 
cpm: a, li ver ca rcino ma; b, cervica l carcinoma ; c, malignant glioma; d, 
neutroblastoma; e, bladder ca rcinoma; J, renal carcino ma; g, choriocar-
cinoma; ii, cultured normal melanocytes following the method of Eisinger 
and Marks [18] . 
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buffer containing 6% SDS, 15% 2-mercaptoethanol, 0.1875 M 
Tris-HCI (pH 6.8), 30% glycerol, and 0.003% bromophenol blue, 
and boiled for 90 s before applica tion. The sample was analyzed 
by one-dimensiona l PAGE. The proteins were transferred to ni-
tro cellulose paper usin g Atto Transwestern AE-3057 apparatus. 
A current of 0.3 amps at 60 V was applied for 2 h. After transfer, 
the nitrocellulose paper was cut into strips and washed with 0.01 
M Tris-HCI (pH 7.5) containing 0.15.M N aCI and 0.05% (vol/vol) 
Tween 20 and trea ted with the MoAb A4Fll and the control 
MoAb foll owed by 1251-labeled ant i mouse immunoglobulin. 
Protein Content Protein content was measured by the Lowr) 
method [24]. Bovine serum albumin was used 3S a standard pro-
tein. 
RES ULTS 
Intracellular Specificity of the MoAb A4Fll The MoAb 
A4Fl1 has been found to react with premelanosoma l and melan., 
osomal fractio ns. In add ition, small granule, rou gh and smooth 
ER fractions exhibit hi gh reactivity with the MoAb, comparing 
with the reactivity of li ver subcellular fract ions. However, the 
mitochondrial fra ction of melanoma also shows moderate reac., 
tivity with the MoAb in indirect RIA (Fig 1). 
Since it is known that the mitochondrial fraction of melanoma, 
contains some unmelanized premelanosomes [14], we furth er ana., 
Iyzed quantitatively the effect of contaminated premelanosomes 
in the mitochondria l fraction . As shown in Fig 2, the rem aining 
activity of the MoAb A4Fll , after absorption by the mitochon, 
drial fract ion of melanoma and liver subcellular fra ctions, has beel, 
found still to be high in comparison with-the marked redu ction 
obtained by premelanosomal fraction. 
Immunoelectron microscopic analysis using the sa ponin per., 
meation method has revealed the localization of the MoAb A4Fll 
on premelanosomes, melanosomes, and Golgi-associated endo-
plasmic reticu lum lysoso l1l.es (GERLs) (Fig 311 ,b) , compared with 
a con trol appearance (Fig 3c). Nuclea r membrane, nuclear matrix, 
mitochondria, and cell cytosol have not been significa ntl y labeled 
by the MoAb A4Fl1 . No distinct labeling of the ER has been 
observed in spite o f positive resu lts with indirect RIA and QAA. 
Further 3-dimensional ultrastructural analysis usin g a high-vol t-
age electron micros cope with goniometer is in process. 
In the Il F test, the MoAb A4Fll has sta ined cu ltured humal\ 
melanoma cells, Mm-l-JCK, and malignant blue nevus cells, a~ 
well· as normal melanocytes with a cytoplasmic granul ar patten\ 
(Fig 411-c) , but the following cultured cell s have not been stained~ 
normal fibrobl as ts (Fig 4d) , normal keratinocytes , HeLa cells (cer, 
vical carcinoma), PLC/PRF/5 (liver ca rcinoma) , HT 1197 (blad, 
der ca rcinoma), KO-RCCI (renal carcinoma). 
Cell Surface Expression of the Antigen(s) Detected by th~ 
MoAb A4Fll Cell binding assay has detected the reactivity 0\1 
the MoAb A4F11 with the cell surface of human melanoma cellI 
such as Mm-l-JCK, Colo 38, SK-MEL-40, and normal l1l.ela, 
nocytes. The MoAb A4Fll has not reacted with mammalia,\ 
melanoma cells such as B16 and Greene's cells, nor with othe~ 
human normal and neo plasti c cells examined (Fig 5). 
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Reactivity of the MoAb A4Fll with Skin Tumor Biopsies 
and Normal Adult Organs (Table II) In the I1F test, the 
MoAb A4F11 has pos itively stained junctional and intradermal 
nevus cells, and primary and metastatic nodu lar melanoma ce lls 
(Fig 6a,b) in contrast to negativel y stained non pigment cell tu-
mors . The MoA b A4Fl1 reactivity among norm al ad ult human 
organs is shown in Ta ble II. The MoAb A4F11 has stained the 
ad renal, gall-bladder, pancreas, tonsils, and epithelial cells of the 
stomach and small intestine, although the intensity of stain ing 
was low. Among the skin components, the melanocy tes and the 
luminal sites of the eccrine secretory portion have been sta ined, 
but the keratinocy tes, in spite of their contained melanosomes, 
have not been signifi ca ntly stained by the MoAb A4F11 (Fig 6c). 
Immunoblot Analysis of the Antigen(s) Detected by the 
MoAb A4Fll We have identi fied a maj or band with 1Vl,50,000 
and minor bands of 18,000 and 17,000 that are reactive w ith the 
MoAb A4F11 , not with the contro l M oAb in immunoblots of 
the J11elanosomal frac ti on of Mm-1-J CK cells, but no t in the small 
gran ule fraction of human norm al liver (Fig 7) . Further biochem-
ical characteriza tion and isolation of this antigen(s) is in process . 
DISCUSSION 
In 1981, Wilson et al [7] were the first to repo rt the MoAb which 
recognized cytoplas mic antigen in human melano ma cells based 
50 KD -
a . h. c . 
Figure 7. Melanosomc preparation of Mm-l-JCK ce lls (tI) and small 
g ranule fra ction ofhulllan norm al li ver (b) illlmunoblottcd with the MoAb 
A4Fll on nitrocel lulose paper. The MoAb A4Fll is reactive with a major 
M, 50,000 band and minor M, 18,000 and 17,000 bands in mc/anosome 
prepara tion, but no t in liver preparation. c, Me/ anosome preparation im-
munoblotted w ith a control MoA b (lgG2b) . 
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Figure 6. The indirect immunofluo res-
cence on intradermal nevus (n, X 115), 
melanom a (b , x 230), and a separated 
cpidermal shee t (c , x 307) using the 
MoAb A4Fll . Mclanocytes (ml'o lvs) have 
been stained distinctively in the sepa-
rated epidermal sheet. 
on flu orescence sta ining pattern and indirect immunoprecipitation 
of [3H]glucosa mine-labeled cell extracts . This M oAb w as de-
scribed to bind only weakly to the cell surface of some melanoma 
cell lines. T he intracellular localiza tion of its cytop lasmic antigen 
within subcellular melanogenic compartments was not described. 
T he report on cell surface express ion of the organ-specific mi-
crosom al antigens in the th yroid gland , gastric mucosa, and ad-
renal g land by Doniach et al [1 2], suggests the sa me antigeni c 
system in melanocy tes, w hich could be thought to be a unicellular 
secretary gland dona tin g melanos0111es into surroundin g kerat-
inocy tes. 
The MoAb A4Fl1 has reacted w ith premelanosomes, mela-
nosomes, and GERLs in human melano tic melanoma cells. Im-
munoelectron microscopic exa mination co uld not reveal the lo-
caliza tion of the M oA b A4Fl1 on . the ER in spite of positive 
results in the indirect RIA and QAA. These conflicting data could 
be due to GERLs contained in Golgi-complex degradation sub-
stances which are known to contaminate the ER fra ction during 
the separation process [1 9] as a marker enzy me shows. 
It has been furth er found that the MoA b A4F11 also reacts wi th 
the cell surface of melanocytes and melanoma cells. The absence 
of reactivity of the MoAb A4F11 with normal human peripheraJ 
lymphocytes has ruled out the possibility that it reacted w ith the 
la-like anti gens known to be present on some melanoma cell lines 
[25,26]. 
T he above ev idence would suggest that there exists a common 
antigen(s) of melanosomes and cell surface in pigment cells, re-
ga rd less of their oncogenic differentiation status, as recognized 
by the MoAb A4F11. Actually, we had predicted the existence 
of such a common :l11tigen(s) before this immunologic study, 
based on our biochemical and ultras tru ctu ra l malyses of the reg-
ul ato ry mechanism of melanogenes is [1 0,11 ], as well as on the 
in terrupted melanogenesis in vitiligo [27-29]. Briefly , melanoma 
cell sur face and melanosomal glycoproteins share an intracellular 
glycosylation and processing pathway after their synthesis at 
mem brane-bound polyribosomes of rough ER and modifica tion 
at Golgi complex. Thereafter they are sorted out and transported 
to th e cell surface and to prcmelanosomes, both of w hich can be 
substantially altered by glycosylation inhibitors. Since these gly-
coproteins having a comm on biochemical synthetic pathway have 
been known to be highl y antigenic [30], it might be worthw hile 
to examine the possi bility that such glycoproteins are recognized 
as antigen(s) by the M oA b A4Fl1. Additionally, the cross-reac-
tivity of the M oA b A4Fl1 w ith secretory glan ds shown in Table 
ll, may indi ca te the possibility th at there exists a C0111mon anti-
genes) on GERLs of such glands because they have no melano-
somes, but are rich in GERL. 
The presence of the common antigen(s) of melanosomes and 
cell surface of pigment cell s found in this study has further sug-
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gested the possibility that melanosomes play an immunologically 
significant role as an antigen in interrupted melanogenesis . Con-
cerning the clinical implication of our findings on the common 
antigen(s) of melanosomes and cell surface, it should be men-
tioned that melanocytes are selectively altered and gradually dis-
appear in the non congenital, progressive depigmentary disorder, 
vitiligo, following the interrupted premelanosome synthesis [27,31] . 
Premelanosomes and melanosomes were found by our group to 
possess the antigenicity revealed by the blastogenic responses of 
lymphocytes from melanoma-bearing hamsters [9] . Recently, 
Naughton et al [32] have detected the antibodies to melanocytes 
in vitiligo patients' sera by specific immunoprecipitation. Betterle 
et al [33] reported the cytoplasmic melanocyte antibodies in vi-
tiligo patients. Vitiligo is also known to be frequently associated 
with disorders of the immune system [34] and discussed as an 
autoimmune disease. In spite of distinct antigenicity of melano-
somes in melanin synthesizing cells, the fact that m elanosomes 
transferred in surrounding keratinocytes lose their antigenicity 
(Fig 6c) may play a critical role in governing genetically deter-
mined epidermal melanin units, and their derangement is being 
investigated in relation to the immunopathogenesis of vitiligo 
depigmentation. 
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